Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Multiple Myeloma 1Lymphoproliferative Disorders 1Laryngeal Neoplasms 1Histiocytosis, Langerhans-Cell 1Hematologic Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1Erdheim-Chester Disease 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

lutetium Lu 177 dotatate 2Fluorouracil 2Everolimus 2trametinib 1toripalimab 1fosbretabulin 1fluorocholine 1dabrafenib 1combretastatin 1cobimetinib 1anlotinib 1Water 1Vemurafenib 1Testosterone 1Temozolomide 1Somatostatin 1Sodium Iodide 1Sodium Chloride 1Sirolimus 1Radiotherapy 1Radiofrequency Ablation 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1PE regimen 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Injections 1Erythromycin 1EC regimen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × trametinib × Endocrine × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡